Physician profile
Michael Schwartz
NPI 1801824099
$1,286.35
in general payments reported to CMS, 2019-2025
20 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $621 · 2020: $120 · 2021: $145 · 2022: $103 · 2024: $176 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $215.82 | 2019-2020 | |
| Janssen Biotech, INC. | $148.05 | 2021-2025 | Rybrevant, Darzalex, Tecvayli |
| Stryker Corporation | $126.95 | 2019-2025 | Audion Et Dilation System |
| Smith+Nephew, INC. | $118.76 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $108.82 | 2019-2024 | Dupixent |
| Alk-Abello, INC | $93.99 | 2019 | |
| Optinose US, INC. | $85.84 | 2019-2025 | |
| Clozex Medical INC | $61.67 | 2021 | |
| Novartis Pharmaceuticals Corporation | $50.00 | 2019 | |
| Allergan, INC. | $46.00 | 2019 | |
| Aveo Pharmaceuticals, INC. | $44.96 | 2024-2025 | |
| Inspire Medical Systems, INC. | $28.69 | 2024 | Inspire |
| Pharming Healthcare, INC. | $25.34 | 2022 | |
| Integra Lifesciences Corporation | $22.74 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.11 | 2024 | Ninlaro |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $20.02 | 2019 | |
| Medtronic, INC. | $18.74 | 2024 | Propel |
| Janssen Pharmaceuticals, INC | $16.56 | 2022 | |
| Glaxosmithkline, LLC. | $16.37 | 2025 | Nucala |
| Teva Pharmaceuticals USA, INC. | $14.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.